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transcript  was  substantially  reduced  while  TNFR2  remained 
unchanged. Crohn’s Disease (CD) and ulcerative colitis (UC) are 
the two forms of inflammatory bowel diseases (IBD). Although 
the etiology remains unknown, a large body of work has demon-
strated that the involvement of damaged epithelia and activated 
immune cells in the inflamed mucosa play important role in their 
pathogenesis (McKay et al., 1996; Targan et al., 1997; Nielson et al., 
2000; Bruewer et al., 2003). In addition to the problem of persistent 
intestinal inflammation in IBD, one of the critical complications 
in patients with long-standing IBD over ∼10 years after onset is 
colitis-associated cancer (Rutter et al., 2004).
Tumor necrosis factor alpha has been implicated in the devel-
opment of colitis (Rutter et al., 2004; Belenkaya et al., 2008) 
and pharmacological blockade with monoclonal antibodies has 
demonstrated great efficacy in treatment of IBD patients (Pan 
et al., 2008). Using mice deficient in type 1 TNF receptor (p55/
TNFR1) Popivanova et al. (2008) used the AOM/DSS model of 
colitis-associated cancer and compared wild type with TNFR1 
knockout mice. Abrogation of TNF signaling ameliorated their 
colitis (as assessed by reduced tissue injury, inflammatory cell 
infiltrates, and cytokine expression in the mucosa). Loss of TNF 
IntroductIon
Increased intake of dairy foods and calcium (Ca2+) has recently 
been shown to dramatically lower the risk of colorectal cancer in 
men and women (Lee et al., 2010). The molecular mechanism(s) 
responsible for this reduction are unknown (Park et al., 2009). 
Tumor  necrosis  factor  alpha  (TNFα),  a  potent  inflammatory 
cytokine, is a critical requirement for the development of col-
itis-associated colon cancer (Popivanova et al., 2008). A major 
target of increased dietary calcium is the extracellular calcium-
sensing receptor (CaSR; Brown and MacLeod, 2001), a G-protein 
coupled receptor, which is present on both colonic epithelia and 
sub-epithelial myofibroblasts (MacLeod et al., 2007; Peiris et al., 
2007; Pacheco and MacLeod, 2008). Our laboratory has demon-
strated that a unique paracrine axis exists, in vitro, which may be 
stimulated by Ca2+ activating the CaSR on colonic epithelia and 
the subepithelia which inhibits proliferation and stimulates dif-
ferentiation (MacLeod et al., 2007; Pacheco and MacLeod, 2008). 
This axis is the production of both Wnt5a from the sub-epithelial 
myofibroblasts and Ror2, an orphan tyrosine kinase which works 
as a receptor for Wnt5a, on the epithelia. Screening Wnt5a/Ror2 
on intestinal epithelia by microarray, we observed that TNFR1 
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Tumor necrosis factor alpha (TNFα) and its receptor  TNFR1 play a central role in the development 
of colitis-associated colon cancer. To understand a role for the extracellular calcium-sensing 
receptor (CaSR) and its non-canonical Wnt mediators, Wnt5a/Ror2, we used reductionistic 
systems. We added lipopolysaccharide (LPS) to mouse peritoneal macrophages, RAW264.7 
cells, a murine macrophage cell line, and 18Co colonic myofibroblasts, to stimulate TNFα 
secretion and then activated endogenous CaSR. CaSR activation inhibited TNFα secretion, 
which in RAW264.7 cells knockdown of CaSR by short-interfering RNA (siRNA) duplex reversed. 
LPS-stimulated NFκB promoter activity in RAW264.7 cells was inhibited by CaSR activation 
with Ca2+ or other polyvalent CaSR agonists. Reducing CaSR expression with siRNA duplex 
prevented this inhibition. Following LPS addition to CaSR–HEK cells or RAW264.7 macrophages, 
CaSR stimulation deneddylated Cullin1. Wnt5a added to HT-29 cells which overexpressed Ror2 
or T84 monolayers treated with 3 mM Ca2+ reduced TNFR1 protein expression ∼70%. TNFα/
INFγ addition to high resistance  T84 monolayers reduced transepithelial resistance 50% within 
4 h. CaSR activation (3 mM Ca2+) together with rhWnt5a (200 ng/ml) prevented this reduction 
while Wnt3a addition had no effect. LPS-stimulated TNFα secretion from RAW264.7 cells was 
not effected by rhWnt5a but increased 10-fold by Wnt3a. Together our results suggest that 
following LPS challenge, CaSR activation will inhibit NFκB activity and reduce TNFα secretion 
from macrophages and stroma while Wnt5a/Ror2 engagement on intestinal epithelia reduces 
TNFR1 expression, allowing  TNFα signaling to be titrated. Our results also suggest that canonical 
Wnt signaling may enhance TLR4 stimulation of TNFα secretion from murine macrophages.
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(tumor  number  and  size).  Further  work  demonstrated  the 
importance of TNFR1 deletion on the immune cells rather than 
the intestinal epithelia, consistent with the interpretation that 
TNFα production in mucosa by resident cells was required for 
activation of the immune cells, which in turn were important 
in the subsequent development of the colon cancer-i.e., TNFα 
was needed to stimulate a tumor promoting immune response. 
A strong candidate of a mediator of NF-κB activation in the 
epithelia of IBD patients is TNFα, which is markedly elevated 
in the inflamed intestinal milieu (Pan et al., 2008). A predomi-
nant source of TNFα is from macrophages. A major source of 
macrophages in the lamina propria is from the peritoneum. 
The kinetics of the phenotype and function of murine perito-
neal macrophages following acute inflammation have been well 
described (Calorini et al., 2000; Wu et al., 2004).
In this study we show that when LPS stimulates TNFα secretion 
from peritoneal macrophages, a mouse macrophage cell line, or 
human colonic myofibroblasts, CaSR stimulation by Ca2+ inhib-
its both NFκB activity and TNFα secretion. We also report that 
CaSR-stimulated Wnt5a-Ror2 mediates downregulation of TNFR1 
transcript and protein on colonic epithelia. We then show that Ca2+ 
and Wnt5a added to high resistance T84 monolayers are protected 
from barrier dissolution triggered by TNFα/INFγ addition. In addi-
tion, we report that the CaSR can modulate Wnt protein secretion 
from macrophages and that canonical Wnt signaling can enhance 
TNFα production from LPS-stimulated macrophages. CaSR acti-
vation together with Wnt5a/Ror2 stimulation may afford a novel 
mechanism to titrate TNFα signaling.
MaterIals and Methods
MaterIals
Wnt3a and Wnt5a antibodies, rhWnt5a, TNFα, and INFγ were 
obtained from R&D systems (Minneapolis, MN, USA). TNFR1, 
TNFR2, Cullin-1, and Nedd8 antibodies were obtained from Cell 
Signaling Technology (Boston, MA, USA). Monoclonal anti-β-
actin, Neomycin sulfate and Spermine were from Sigma (Saint 
Louis, MO, USA). Cell culture media Dulbecco’s Modified Eagles 
Media, with or without calcium were obtained from GIBCO-BRL 
(Grand Island, NY, USA). The enhanced chemiluminescence super-
signal kit was from Pierce (Rockford, IL, USA). LPS was a gift from 
Dr. Elaine Petrof (Queen’s University, Kingston, ON, Canada).
cell culture
The human colon adenocarcinoma HT-29 cell line, T84 mon-
olayers,  colonic  myofibroblast  cells,  and  murine  macrophages 
RAW264.7  were  purchased  from  the  American  Type  Culture 
Collection (ATCC; Rockville, MD, USA). Mouse peritoneal macro-
phages were isolated as previously described (Quesniaux et al., 2010; 
Wehner et al., 2010). The protocol was approved by the University 
Animal Care Committee. CaSR-transfected HEK cells were a gift 
from Ed Brown (HMS, Boston, MA, USA). HT-29, RAW264.7, 
CaSR–HEK cells were grown in Dulbecco’s modified eagle media 
(DMEM) supplemented with 10% fetal bovine serum (FBS), and 
1.0% PenStrep (all purchased from Invitrogen, Carlsbad, CA, USA). 
The colonic myofibroblasts were cultured in Minimum essential 
medium supplemented with 10% FBS and 1.0% PenStrep. All cells 
were maintained at 37°C, in 95% air, 5% CO2 atmospheric condi-
tions. Cells were passaged weekly with 0.25% trypsin (except for the 
RAW264.7 cells which were scraped) and used for experimentation 
within the first six passages.
PreParatIon of Wnt3a and Wnt5a condItIoned MedIa
Mouse L-cells, stably transfected with either Wnt3a or Wnt5a 
plasmid, were seeded on 10 cm plates and supplemented with 
10% DMEM, as previously described. After 24 h, cells were then 
incubated in 0.5 mM Ca2+ DMEM containing 0.1% l-Glutamine 
and 1.0% PenStrep and supplemented with 0.2% bovine serum 
albumin. This media was collected 48 and 96 h afterward. Upon 
collection, media was centrifuged at 175 × g for 5 min and the 
remaining supernatant was isolated, divided into aliquots, and kept 
at −30°C for later use.
short-InterferIng rna duPlex generatIon and transfectIon
Short-interfering  RNA  (SiRNA)  duplexes  against  the  CaSR 
were synthesized following the protocol we previously reported 
(MacLeod et al., 2007; Peiris et al., 2007; Pacheco and MacLeod, 
2008). Briefly after BLAST analysis of target sites in the extracel-
lular domain of the CaSR, we synthesized siRNA directed against 
nucleotides 371–390 utilizing a siRNA Construction Kit (Silencer 
siRNA Construction Kit, Ambion) according to the manufacturer’s 
protocol. RAW264.7 cells were transfected with 50 nM of either 
siRNA against the CaSR or the scrambled sequence using Superfect 
reagent following manufacturer’s instructions (Qiagen, Valencia, 
CA, USA).
transIent transfectIons and Western BlottIng
All DNA plasmid transfections completed for subsequent Western 
blot  analysis  were  performed  using  the  Superfect  transfection 
reagent, according to the manufacturer’s instructions (Qiagen, 
Mississauga, ON, Canada).
For the TNFR1 westerns, HT29 cells were transiently trans-
fected with 1 μg of either pcDNA3.1 or WT–Ror2 for 24 h, serum 
starved in 0.5 mM CaCl2 DMEM for 24 h and treated with Wnt5a 
conditioned medium (CM) for 18 h. Cells were washed twice 
with ice-cold phosphate-buffered saline (PBS) containing 1 mM 
sodium vanadate and 25 mM NaF, and then 100 μl of ice-cold 
lysis buffer was added (20 mM Tris HCL, pH 7.4, 150 mM NaCl, 
1 mM EDTA, 1 mM EGTA, 25 mM NaF, 1% Triton X-100, 10% 
glycerol, 1 mM dithiothreitol, 1 mM sodium Vanadate, 50 mM 
glycerophosphate, and a cocktail of proteases inhibitors (10 μg/
ml each of aprotinin, leupeptin, calpain, pepstatin, and soybean 
trypsin inhibitor as well as 100 μg/ml Pefabloc). NaF, sodium 
vanadate, and Pefabloc were freshly prepared on the same day of 
the experiments. After sonicating for 5 s, lysates were centrifuged 
at 10,000 × g for 10 min at 4°C and processed as described (37). 
TNFR1 was detected using a 1:1000 dilution of primary antibody 
in TBS containing 0.1% Tween 20 (v/v) and 5% BSA. β-actin was 
detected with 1:10,000 dilution of primary antibody in TBST 
with 5% milk.
To measure Cullin-1 denedylation in the presence of calcium, 
CaSR–HEK cells were incubated in serum-free, 0.5 mM CaCl2 
DMEM for 24 h and treated with 10 ng/ml LPS in the presence of 
either 0.5 mM CaCl2 or 3 mM CaCl2 for 18 h. Lysates were prepared 
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Co-transfection with thymidine kinase–Renilla, which displays 
constitutive low levels of activity, was used as an internal control 
against which to normalize the NF-κB luciferase data. Experiments 
were performed in triplicate.
transePIthelIal electrIcal resIstance MeasureMents
T-84 epithelial cells were seeded to form confluent monolayers as 
to develop high electrical resistance on Transwell permeable sup-
ports (area of 0.33 cm2) in 24 well plates (Corning Inc.; Corning, 
NY, USA). The transwells filters were pre-coated in our laboratory 
with collagen (Sigma, Oakville, ON, Canada). The transepithe-
lial resistance was measured using an epithelial voltmeter (WPI, 
Inc; Sarasota, FL, USA) and STX2 electrodes. High resistance T84 
monolayers were treated overnight with 3 mM CaCl2 and treated 
with either 2.5 ng/ml INFγ in the basolateral reservoir and 10 ng/
ml TNFα to both sides or TNFα alone. Wnt5a CM was added to 
both treatments for 4 h and the effect on transepithelial electrical 
resistance (TER) was measured.
statIstIcs
Data are presented as means ± SE of at least three separate experi-
ments. Data were analyzed by Student’s t-test or ANOVA when 
appropriate. p < 0.05 was set as the statistically significant differ-
ence level.
results
hIgh ca2+ (3 mM) InhIBIts lPs-stIMulated tnfα secretIon froM 
PerItoneal MacroPhages, raW264 MacroPhages and 18co 
colonIc MyofIBroBlasts
As CaSR expression has been reported in macrophages (Olszak 
et al., 2000) and colonic myofibroblasts (Peiris et al., 2007; Pacheco 
and MacLeod, 2008), we stimulated TNFα secretion from these cells 
by incubation with LPS (10 ng/ml), then compared the amount 
of TNFα secretion in medium containing LPS and either low Ca2+ 
(0. 5 mM) or high Ca2+ (3.0 mM). CaSR activity is stimulated by 
3 mM Ca2+ and not activated in 0.5 mM Ca2+. The high Ca2+ addi-
tion  significantly  reduced  the  LPS-stimulated  TNFα  secretion 
from mouse peritoneal macrophages (Figure 1A), from a mouse 
macrophage cell line, RAW264 (Figure 1B) and from the colonic 
as described above. Western analysis was done using a 1:1000 dilu-
tion of both Cullin-1 and Nedd8 antibodies in TBS containing 0.1% 
Tween 20 (v/v) and 5% BSA.
For the determination of Wnt3a or Wnt5a from RAW264.7 
cells, early passage cells were grown on 100 mm dishes. Cells were 
transiently transfected with 1 μg of either WT–CaSR or DN–CaSR 
(R185Q) for 24 h, incubated for 24 h in serum-free, 0.5 mM Ca2+ 
DMEM (as above). This medium was removed and substituted 
with the same medium supplemented with 0.5 mM Ca2+ or 3 mM 
Ca2+, or 0.5 mM Ca2+ with LPS (10 ng/ml) for 18 h. At the end of 
the incubation period (18 h), CM was harvested and concentrated 
to 16× by Amicon Ultra filter devices (Millipore, Carrigtwohill, 
Ireland). Cell lysates were prepared as above. Western blot analysis 
was done as previously described (MacLeod et al., 2007).
For all western analysis, bands were visualized by chemilumines-
cence as previously described. Quantitation of the bands was done 
using NIH Image J v1.34 and a Personal Densitometer (Molecular 
Dynamics).
tnfα elIsa analysIs
Cells  were  seeded  in  24-well  plates  (Sarstedt,  Montreal,  QC, 
Canada), incubated in serum-free, low Ca2+ medium for 18 h fol-
lowed by 6 h treatments. CM was collected and resuspended in 
300 μL. The amount of secreted TNFα was measured using a TNFα 
Quantikine ELISA kit (R&D, Minneapolis, MN, USA) as per manu-
facturer’s instructions.
lucIferase rePorter assay
RAW264.7 cells were seeded in 24-well plates and transiently trans-
fected 24 h later with 2 μg of NF-κB response element-driven firefly 
luciferase reporter plasmid (Clontech, Palo Alto, CA, USA) and 
0.2 μg of thymidine kinase promoter-driven Renilla reporter plas-
mid (Promega) using PolyFect transfection reagent as per manu-
facturer’s instructions (Qiagen, Mississauga, ON, Canada). Cells 
were serum starved in 0.5 mM CaCl2 DMEM for 18 h and treated 
with 10 ng/ml LPS and either 0.5 mM CaCl2 or 3 mM CaCl2 for 
6 h. Neomycin Sulfate and Spermine where required were added 
with LPS. Cells were harvested and NF-κB luciferase assays were 
performed by using the Dual Luciferase Assay according to the man-
ufacturer’s instructions (Promega). Luminescence was   measured 
FiguRe 1 | High calcium inhibits LPS-stimulated TNFα secretion from 
mouse peritoneal macrophages (A), mouse macrophage (RAW264) (B), and 
colonic myofibroblasts (C). Cells were serum starved for 18 h and treated with 
LPS in serum-free medium supplemented with either 0.5 mM CaCl2 or 3 mM 
CaCl2. The amount of TNFα secretion was measured using a TNFα ELISA. 
*p < 0.05, n = 3.
Kelly et al.  CaSR-Wnt5a inhibits TNF signaling
www.frontiersin.org  May 2011  | Volume 2  | Article 17  |  3added with LPS had a comparable effect significantly inhibiting 
the LPS-stimulated activity (Figure 2B). In cells transiently trans-
fected with siRNA duplex against the CaSR and exposed to 3 mM 
Ca2+ and LPS as in the earlier experiments, there was no inhibi-
tion of LPS-stimulated NFκB reporter activity. Cells transfected 
with scrambled siRNA duplex and exposed to 3 mM Ca2+ and LPS 
had significantly less activity compared with cells transfected with 
siRNA duplex against the CaSR (% RLU of 0.5 mM Ca2+ + LPS: 
46 ± 8 vs 112 ± 9, p < 0.05, n = 4). These experiments suggested 
CaSR stimulation was inhibiting NFκB activity, which could lead 
to a reduction in TNFα secretion.
casr actIvIty results In deneddylatIon of cullIn1 In heK and 
raW264 MacroPhages
NFκB activity requires the E-type ubiquitin ligase Cullin1 to ubiq-
uitinate IκB. The ability of Cullin1 to work this way requires it to 
be covalently modified with Nedd8. To determine whether CaSR 
influenced the status of Cullin1, we challenged both stably trans-
fected CaSR–HEK cells and RAW264 cells in the presence of LPS 
with either low Ca2+ (0.5 mM) or high Ca2+ (3 mM) medium and 
18 h later prepared lysates and measured by Western blot both Nedd8 
and Cullin1 (Figure 3). Cells in the low Ca2+ medium with LPS had 
the characteristic two molecular weights of Cullin1, representing 
the covalently modified Cullin1 (as Cullin1–Nedd8) and the lower 
weight Cullin1. These cells also expressed immunoreactive Nedd8. In 
contrast, cells treated with 3 mM Ca2+ in the presence of LPS had sub-
stantially reduced Cullin1–Nedd8. The ratio of Neddylated Cullin1/
Cullin1 in the RAW264.7 cells was significantly reduced compared 
with cells treated with 0.5 mM Ca2+ and LPS (38 ± 9%, p < 0.05, n = 3). 
Comparable reduction of the ratio of neddylated Cullin1/Cullin1 
was also observed in the CaSR-transfected HEK cells. Treatment of 
non-transfected HEK cells with low and high Ca2+, in a   comparable 
myofibroblasts (Figure 1C). The most TNFα was secreted from 
the peritoneal macrophages, while the least was from the myofi-
broblasts. The amounts of LPS-stimulated TNFα from these two 
types of cells varied by two orders of magnitude, with the RAW264 
macrophage cell line secreting 10-fold less then the peritoneal cells. 
Addition of high Ca2+ inhibited the LPS-stimulated TNFα secretion 
comparably in all three cell types.
casr MedIates InhIBItIon of lPs-stIMulated tnfα secretIon 
and nfκB ProMoter actIvIty
To determine if the CaSR-mediated the effects of high Ca2+ on the 
LPS-stimulated TNFα secretion, we used RAW264 cells and first 
compared other well established CaSR agonists added with LPS in 
low Ca2+ (0.5 mM) medium. We then we knocked down expression 
of the CaSR by transient transfection with siRNA duplex directed 
against the CaSR compared with cells transfected by a scrambled 
siRNA duplex (Figure 2A). Both Neomycin sulfate (350 μM) and 
spermine (2 mM) added in low Ca2+ medium together with LPS 
significantly reduced the LPS-stimulated TNFα secretion. Transient 
transfection with siRNA against the CaSR prevented the high Ca2+ 
inhibition of the LPS-stimulated TNFα (Figure 2A). The amount of 
TNFα secreted from the RAW264 cells transfected with a scrambled 
siRNA duplex and treated with 3 mM Ca2+ was significantly less then 
from cells comparably treated but transfected with siRNA against 
the CaSR (pg TNF/ml/6 h: 2048 ± 112 vs 9659 ± 1082, p < 0.05, 
n = 4). Together, these experiments strongly suggest that CaSR 
activation was responsible for the inhibition of LPS-stimulated 
TNFα secretion from the RAW264 macrophages. Because LPS will 
activate TNFα synthesis through an NFκB pathway, we then asked 
if CaSR activation altered LPS-stimulated NFκB reporter activity 
in the RAW264 cells (Figure 2B). High Ca2+ (3 mM) and other 
CaSR agonists (Neomycin sulfate, 350 μM) or spermine (2 mM) 
FiguRe 2 | Calcium-sensing receptor mediates high calcium inhibition of 
LPS-stimulated TNFα secretion and NFκB activity from RAW264.7 
macrophages. RAW264 cells were transfected with 50 pmol of either 
Scrambled SiRNA or SiRNA against CaSR [and a NFκB luciferase reporter in (B)] 
for 24 h, serum starved in 0.5 mM CaCl2 for 18 h and treated with 10 ng/mL LPS 
and either 0.5 mM CaCl2 or 3 mM CaCl2 for an additional 6 h. Neomycin sulfate 
and Spermine were added with LPS in the appropriate samples. (A) Conditioned 
medium was used in a TNFα ELISA to measure the secretion of TNFα. (B) 
Lysates were recovered and a dual luciferase assay was done to measure the 
NFκB reporter activity. *p < 0.05, n = 4.
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of TNFR2. Western blot of HT-29 cells comparably treated demon-
strated that Wnt5a/Ror2 decreased TNFR1 protein ∼70% (Figure 4) 
compared with cells transfected with empty plasmid. T84 cells grown 
on Transwells for 12 days to generate a high transepithelial resistance 
(TER = 3000 Ω/cm2) were first incubated treated overnight with 
3 mM Ca2+ (to increase Ror2), then rhWnt5 (200 ng/ml) was added 
for a further 12 h, Western blot analysis demonstrated a comparable 
reduction in TNFR1 protein (83 ± 4%, n = 4, p < 0.05) compared 
with monolayers which did not receive rhWnt5a addition.
Wnt5a/ror2/casr Prevents declIne In ter stIMulated By tnfα In 
t84 Monolayers
Using high resistance T84 monolayers, we first treated these cells 
overnight with 3 mM Ca2+, to increase expression of Ror2. We then 
either “primed” the monolayer by adding INFγ (2.5 ng/ml) to the 
  fashion, demonstrated no   differences in the ratio of Neddylated 
Cullin1/Culllin1 (0.74 ± 0.04 vs 0.76 ± 0.07, n = 3). These results 
strongly suggest that CaSR activation in both RAW264 macrophages 
and CaSR-transfected HEK cells stimulates deneddylation of Cullin1.
Wnt5a/ror2 reduces exPressIon of tnfr1 (p55) on ht-29 and t84 
Monolayers
Tumor necrosis factor alpha will signal through two receptors, p55 
and p75 (TNFR1 and 2 respectively). Because it had been shown 
earlier that CaSR activation would increase expression of Ror2 on 
intestinal epithelia, and that CaSR activation of colonic myofibrob-
lasts would stimulate secretion of Wnt5a (Pacheco and MacLeod, 
2008), we asked if Wnt5a/Ror2 engagement influenced expression of 
TNFR1. Ror2 was overexpressed in HT-29 cells and rhWnt5 added to 
the cells 48 h later and allowed to incubate for 18 h. Semi-quantitative 
RT-PCR analysis of cDNA from these cells demonstrated Wnt5a/
FiguRe 3 | Calcium-sensing receptor activation stimulates denedylation of Cullin-1. CaSR–HEK and RAW264 cells were serum starved for 18 h in 0.5 mM 
CaCl2 and treated with 10 ng/ml LPS in the presence of either 0.5 mM CaCl2 or 3 mM CaCl2.
FiguRe 4 | Wnt5a/Ror2 decrease TNFR1 protein expression. HT29 cells were 
transiently transfected with 1 μg WT–Ror2 (or 1 μg pcDNA3.1 as a control) for 
24 h, serum starved for 24 h and treated with Wnt5a conditioned medium for 
18 h. Lysates were recovered and western blot analysis demonstrated a 70% 
reduction in TNFR1 protein expression in Wnt5a treated, Ror2 overexpressed 
HT29 cells. *p < 0.05, n = 4.
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These results suggest the CaSR can mediate Wnt protein secretion 
from macrophages and that the canonical Wnt protein, Wnt3a, can 
increase TNFα secretion from macrophages.
dIscussIon
Our current findings are illustrated in the accompanying schematic 
(Figure 7). In the current experiments we demonstrate that follow-
ing LPS challenge, mouse peritoneal macrophages, a mouse mac-
rophage cell line, RAW264.7, and a human colonic myofibroblast 
cell line, 18Co, responded to increased extracellular calcium with 
a reduction in TNFα secretion. The mediator of inhibition was 
the extracellular CaSR, as knockdown of the CaSR reversed both 
the high Ca2+-mediated inhibition of TNFα secretion and LPS-
stimulated NFκB reporter activity. CaSR stimulation was found 
to deneddylate Cullin1, consistent with a mechanism which could 
inhibit NFκB activity. Because CaSR stimulation will increase Wnt5a 
secretion from colonic myofibroblasts while on the overlying epi-
thelia CaSR stimulation increases amounts of the Wnt5a recep-
tor, Ror2, we assessed whether TNFα induced damage to a model 
epithelial barrier was influenced by Wnt5a. Addition of Wnt5a 
to intestinal epithelia that were overexpressing Ror2 substantially 
reduced protein expression of TNFR1. Exogenous Wnt5a prevented 
TNFα-stimulated decreases in transepithelial resistance in epithe-
lial monolayers, while addition of the canonical signaling Wnt3a 
family member did not influence TNFα-stimulated barrier reduc-
tion. Addition of exogenous Wnt5a did not effect LPS-stimulated 
TNFα secretion from mouse macrophages, while Wnt3a substan-
tially increased LPS-stimulated TNFα secretion from these cells. 
Together our results suggest to us that CaSR stimulation, together 
with the sub-epithelial and epithelial effectors of CaSR stimulation, 
manifested as Wnt5a/Ror2 engagement, can titrate TNFα signaling 
through the combined reduction of TNFα and its receptor TNFR1.
High Ca2+ (3 mM) addition to stimulate the CaSR of macro-
phages and myofibroblasts previously challenged with LPS, reduced 
TNFα secretion. The presence of the CaSR has previously been 
basolateral reservoir and added TNFα (10 ng/ml) to both sides in 
the continued presence of 3 mM Ca2+, or just added TNFα alone 
without priming, and compared the change in TER after 4 h fol-
lowing addition of various Wnt proteins to the apical chamber. 
Without Wnt protein addition, but in the presence of 3 mM Ca2+ 
the TER declined significantly (Ω/cm2: 3105 ± 139 vs 1513 ± 37, 
p < 0.05, n = 6, Figure 5). In the presence of a 1:1 dilution of CM 
from Wnt5a-secreting L-cells, this decline was prevented (Ω/cm2: 
2750 ± 247 vs 2500 ± 180, ND, n = 6), irrespective of the prior 
priming with INFγ (Ω/cm2: 2930 ± 170 vs 2758 ± 69 Ω/cm2, ND, 
n = 6). Addition of rhWnt5a (200 ng/ml) to TNFα/INFγ-primed 
monolayers also inhibited the decline at 4 h (Ω/cm2: 2845 ± 172 vs 
1513 ± 37, p < 0.05, n = 6). Addition of a 1:1 dilution of CM from 
Wnt3a-secreting L-cells did not prevent the TNFα/INFγ reduc-
tion in TER at 4 h (Ω/cm2: 2981 ± 155 vs 1468 ± 148, p < 0.05 
n = 6). These results strongly suggest that Wnt5a, but not Wnt3a, 
can prevent early TNFα induced reduction in TER in model epi-
thelial membranes.
Wnt5a status of raW264.7 cells and Wnt ProteIn effects on 
tnfα secretIon
In a final set of experiments, we asked if CaSR activation altered 
Wnt protein secretion from the macrophages and if Wnt protein 
influenced TNFα secretion. We measured Wnt5a in the CM of 
RAW264.7 cells that had been transiently transfected with either 
wild type CaSR or a natural dominant negative CaSR R185Q, and 
compared the Wnt protein in CM with amount in the lysate by 
Western blot (Figure 6A). Addition of 3 mM Ca2+ for 18 h reduced 
the Wnt5a protein secreted from RAW264.7 cells; overexpression 
of R187Q reduced the inhibition of Wnt5a secretion caused by 
high Ca2+ (Figure 6A). Addition of CM from L-Wnt5a-secreting 
cells had no effect on LPS-stimulated TNFα secretion. Addition of 
rhWnt5a (200 ng/ml) also did not change the amount of TNFα 
secretion from these cells. However, CM from L-Wnt3a-secreting 
cells substantially increased the amount of LPS-stimulated TNFα 
secreted (Figure 6B). Wnt3a CM increased the LPS-stimulated 
FiguRe 5 | Wnt5a prevents reduction in TeR stimulated by TNFα in T84 
monolayers but Wnt3a does not. (A) High resistance T84 monolayers were 
treated overnight with 3 mM CaCl2 and treated with either 2.5 ng/ml INFγ in the 
basolateral reservoir and 10 ng/ml TNFα to both sides or TNFα alone. Wnt5a 
conditioned medium was added to both treatments for 4 h and the effect on TER 
was measured. (B) Monolayers were treated as above with both INFγ and TNFα. 
Either 200 ng/ml rhWnt5a or Wnt3a conditioned medium was added to the 
apical chamber for 4 h and the change in TER was measured. * p < 0.05, n = 6.
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and Wnt3a increases LPS-stimulated secretion of TNFα. (A) RAW264.7 
cells were transiently transfected with 1 μg of either WT–CaSR or DN–CaSR 
for 24 h. Cells were then serum starved in 0.5 mM CaCl2 for 24 h followed 
by treatment with either 0.5 mM CaCl2 or 3 mM CaCl2 for an additional 18 h. 
Both the conditioned medium and lysates were analyzed by Western blot. 
RAW264.7 cells were also treated with LPS (10 ng/ml) and the conditioned 
medium probed with Wnt5a. (B) RAW264.7 cells were serum starved for 
24 h in 0.5 mM CaCl2 and treated with 10 ng/ml LPS and either 200 ng/ml 
rhWnt5a or Wnt3a conditioned medium. Conditioned medium was collected 
and TNFα secretion was measured using a TNFα ELISA kit.*p < 0.0011, 
n = 4.
FiguRe 7 | Multi-cell role of CaSR on TNF signaling. TNFR1 signaling is 
inhibited by CaSR through two mechanisms. CaSR increases the secretion of 
wnt5a from the myofibroblasts, which interacts with Ror2 and leads to a 
decrease in TNFR1 expression. CaSR also inhibits the secretion of TNFα from 
macrophages, thereby interrupting TNFR1 signaling.
shown  on  monocytes/macrophages  and  macrophage  cell  lines 
(Olszak et al., 2000). RAW264.7 is a well defined monocyte/mac-
rophage cell line which has been extensively characterized for its 
macrophage-like responses (Boutdot et al., 2010). Reducing CaSR 
expression using previously characterized siRNA duplex transient 
transfection (MacLeod et al., 2007; Peiris et al., 2007; Pacheco and 
MacLeod, 2008), prevented the reduction caused by high Ca2+ in 
RAW264.7 cells, consistent with CaSR-mediating the inhibition of 
TNFα secretion. Other CaSR polyvalent agonists, such as neomycin 
sulfate and spermine (Brown and MacLeod, 2001), had comparable 
effects as high Ca2+ inhibiting LPS-stimulated NFκB reporter activ-
ity in the macrophage cell line, consistent with CaSR-mediating 
inhibition of NFκB activity. Because siRNA duplex against the CaSR 
prevented the high Ca2+-inhibition of NFκB reporter activity in 
these experiments, we conclude that it was activation of the CaSR 
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signaling in response to exogenous TNFα addition (Singleton and 
Wishmeyer, 2008). It is not known if Wnt5a/Ror2 alter histone 
deacetylase activity in enterocytes.
Wnt5a/Ror2 activation in intestinal epithelia leading to a reduc-
tion in TNFR1 will be addressed in a separate study. Nevertheless, 
Wnt5a prevented the barrier damaging effects of exogenous TNFα 
addition to a model epithelial barrier in the current study. Addition 
of Wnt3a, a prototypical canonical Wnt signaling family mem-
ber, did not prevent the reduction in transepithelial resistance 
we observed after TNFα addition. Consistent with other studies 
(Ye et al., 2006) we interpret the reduction of transepithelial resist-
ance after TNFα addition to increases in paracellular permeability 
because of tight junction disruption. While it is possible that Wnt5a/
Ror2 engagement prevents tight junction disruption by altering 
myosin light chain kinase (MLCK) activity or expression, the sim-
plest explanation of our results is due to the reduction in TNFR1 
protein. We included INFγ in the T84 experiments because others 
had shown that INFγ could prime Caco-2 monolayers to respond 
to TNFα addition by increasing expression of TNFR2 (Wang et al., 
2005, 2006). These studies suggested that the deleterious effect of 
TNFα on epithelial barriers was mediated predominantly through 
TNFR2. Our current studies did not use Caco-2 monolayers. We 
found that with INFγ or without INFγ, the effect of exogenous 
TNFα addition was comparable on T84 monolayer resistance, 
and that the presence of INFγ did not effect Wnt5a prevention of 
the TNFα-induced reduction of transepithelial resistance. We also 
found that Wnt5a/Ror2 engagement did not alter TNFR2 expres-
sion in HT-29 cells and T84 monolayers (data not shown). The 
absence of a “priming” effect of INFγ on the T84 monolayers may 
reflect either expression levels of TNFR2 in these cells, or an effect of 
CaSR activation on TNFR2. Our current results are best described 
as CaSR-mediating an increase in Ror2 on the epithelia (Pacheco 
and MacLeod, 2008) allowing CaSR-mediated Wnt5a (Pacheco and 
MacLeod, 2008) from the sub-epithelial myofibroblasts to engage 
Ror2 leading to a reduction in TNFR1. The reduced TNFR1 pre-
vents TNFα signaling that would otherwise lead to tight junction 
disruption and epithelial barrier loss.
Wnt5a added to RAW264.7 macrophages which were stimulated 
with LPS did not further increase TNFα secretion from these cells. 
However, addition of Wnt3a dramatically stimulated TNFα secre-
tion from these LPS-treated cells. When Wnt secretion into CM 
was assessed, we found that CaSR activation inhibited Wnt5a secre-
tion. We conclude that CaSR-mediated this effect, since transient 
transfection with a dominant negative CaSR, R185Q (Peiris et al., 
2007) restored Wnt5a secretion from the macrophages. While the 
determinants of Wnt protein secretion are currently being eluci-
dated, little is known about how a GPCR like the CaSR can mediate 
the secretion of one Wnt family member over another (Bartscherer 
et al., 2006; Belenkaya et al., 2008; Angers and Moon, 2009; Jin 
et al., 2010; Port and Basler, 2010). Our current results suggest 
that there may be plasticity in regulating the type of Wnt family 
member secreted from native macrophages compared with acti-
vated cells in response to GPCR activation. In this regard, recent 
studies have demonstrated distinct effects of Wnt5a and Wnt3a in 
human   macrophages. TLR2 and TLR4 activation by Mycobacterium 
tuberculosis increased expression of Wnt5a and Frizzled5 (Fzd5; 
which mediated the inhibition of NFκB activity to subsequently 
reduce LPS-stimulated TNFα secretion from the macrophages. 
CaSR activation has previously been shown to increase TNFα 
production in mTAL cells, through pertussis toxin-sensitive and 
PKC requiring pathway(s) (Wang et al., 2003; Abdullah et al., 2008). 
Indeed, in mature rabbit osteoclasts, calcium-sensing receptor acti-
vation has been shown to stimulate nuclear translocation of NFκB 
(Mentaverri et al., 2006). These studies differ from our current 
studies as they did not use LPS to stimulate NFκB prior to CaSR 
activation. Our current studies suggest that CaSR activation after 
NFκB has been stimulated (at least through TLR4 activation) inhib-
its NFκB activity, leading to inhibition of LPS-stimulated TNFα 
secretion. We speculate that CaSR stimulation generates a negative 
feedback inhibition of Toll-like receptor mediated NFκB activation 
in macrophages and stromal cells.
Insight into how CaSR activation inhibits NFκB activity came 
from our experiments measuring the amount of neddylated Cullin1 
in macrophages and CaSR-transfected HEK cells. Inhibitors of 
NFκB (IκBs) hold the NFκB transcription factors in the cyto-
plasm (Cardozo and Pagano, 2004). Proteosomal degradation of 
IκB proteins that inhibit NFκB is a highly regulated process. The 
E3 SCF ubiquitin ligase specific to IκB family members comprising 
SKP1, Cullin1, and the F-box domain of β-TrCP, is responsible for 
the polyubiquitination of IκB (Read et al., 2000; Pan et al., 2004; 
Khoury et al., 2007). The activity of the E3 ligases requires the 
regulatory subunit of Cullin1 to be posttranslationally modified 
by the ubiquitin-like protein Nedd8. Loss of Nedd8 modification 
results in loss of SCF activity. Deneddylated Cullin1 is incapable of 
ubiquitination of IκB. Lack of ubiquitination of IκB generates inac-
tivation of NFκB. Adenosine activating the A2b receptor inhibits 
TNFα secretion from macrophages by stimulating deneddylation of 
Cullin1 (Khoury et al., 2007). Glutamine will also stimulate dened-
dylation of Cullin1, reducing NFκB signaling and TNFα release in 
a post-sepsis model, but the status of TNFR1 was not addressed 
in these studies (Singleton and Wishmeyer, 2008). Because CaSR 
activation will reduce the ratio of neddylated Cullin1 to Cullin1, our 
results suggest to us that CaSR stimulation inhibits NFκB activity 
at the level of proteosomal degradation of IκB proteins. Further 
studies are required to identify the signalosome responsible for the 
loss of Nedd8 modification after CaSR stimulation.
Wnt5a added to epithelial cells where Ror2 was either overex-
pressed or increased by CaSR activation, reduced expression of 
TNFR1, and prevented TNFα-induced changes in transepithelial 
resistance of a model epithelial barrier. Wnt5a/Ror2 engagement 
has been shown to increase CDX2 expression and sucrase–iso-
maltase expression in model epithelia (Pacheco and MacLeod, 
2008). The signaling cascades responsible for the former increases 
are JNK, Casein kinase, and Src kinase activation, while Wnt5a/
Ror2 production of villin requires only pERK activation. Wnt5a/
Ror2 signaling has recently been reviewed (Minami et al., 2010; 
Nishita et al., 2010; Sato et al., 2010) and appears both cell and 
tissue specific, highlighting that in many cell types, Ror2 will also 
work as a co-receptor allowing canonical Wnt signaling to occur. 
Nevertheless  Wnt5a/Ror2  activation  reduced  TNFR1  protein 
expression  substantially  in  model  intestinal  epithelia.  Histone 
deacetylase inhibitors added to non-small lung cell cancer cells 
down-regulate TNFR1 transcript and protein, as well as reduce 
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of the non-absorbed calcium may reach the colon. With increased 
dietary calcium the non-absorbed fraction may be proportionately 
increased, to activate the CaSR to stimulate Wnt5a/Ror2 interac-
tion and signaling. Further work using in vivo models is required 
to understand agonist stimulation of the CaSR in the settings of 
the colon.
In summary we report that following LPS-stimulation of peri-
toneal macrophages, a murine macrophage cell line and colonic 
myofibroblasts,  activation  of  the  extracellular  CaSR,  reduced 
NFκB promoter activity and TNFα secretion. This reduction 
may  be  due  to  CaSR  stimulation  causing  deneddylation  of 
Cullin1. In model epithelial cells and monolayers, the previously 
documented non-canonical Wnt signaling cascade mediated by 
the CaSR–Wnt5a interacting with Ror2, substantially reduced 
TNFR1 protein. Exogenous Wnt5a, but not Wnt3a, when added 
to epithelial barriers which had been treated with high Ca2+ to 
activate the CaSR (to produce more Ror2) were protected from 
barrier disruption caused by TNFα/INFγ addition. Activation of 
the CaSR on the macrophage cell line altered Wnt protein secre-
tion, and in macrophages treated with LPS, Wnt3a substantially 
enhanced TNFα secretion. We conclude that our results suggest 
that after LPS-stimulation, CaSR activation of macrophages, epi-
thelia, and subepithelia working together can titrate the effects 
of increased TNFα on the intestinal barrier to generate a novel 
anti-inflammatory effect.
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